Skip to main content

Table 3 Pregnancy outcomes

From: Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome

Parameter

Non-overweight

Overweight

P value

Non-HA

(n = 218)

HA

(n = 152)

Non-HA

(n = 117)

HA

(n = 96)

Clinical PR

49.7% (76/153)

43.6% (41/94)

40.9% (36/88)

43.7% (31/71)

NS

Miscarriage rate

14.5% (11/76)a

26.8% (11/41)

30.6% (11/36)

45.2% (14/31)b

<0.05

Live-birth rate

42.5% (65/153)a

31.9% (30/94)

28.4% (25/88)b

23.9% (17/71)b

<0.05

Ectopic PR

3.3% (5/153)

0% (0/94)a

5.7% (5/88)b

0% (0/71)

<0.05

Singleton PR

60.5%(46/76)

56.1%(23/41)

58.3% (21/36)

58.1% (18/31)

NS

Twin PR

39.5%(30/76)

43.9%(18/41)

41.7% (15/36)

41.9% (13/31)

NS

Preterm rate

22.4%(17/76)

19.5%(8/41)

19.4% (7/36)

12.9% (4/31)

NS

Full term rate

63.2%(48/76)

53.7%(22/41)

50.0%(18/36)

41.9% (13/31)

NS

CS rate

72.3% (47/65)

70.0% (21/30)

84.0% (21/25)

94.1% (16/17)

NS

  1. HA hyperandrogenemia; PCOS polycystic ovary syndrome; BMI body mass index; NS not significant; PR pregnancy rate; CS caesarean section
  2. a Significantly different from b groups